Pre commercialization biotechnology companies always burn cash. It is the nature of the business. It can take decades to bring new therapies to market, as the FDA has a high bar for approval. However if there is a nod from the FDA for an early approval, then raising cash is much easier. With the announcements made already this year, Silviu can easily do a road show and raise whatever he needs for MSB.
Biotech companies have some of the wildest rides in the market. I think this one shall be an epic one ))
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-294
-
- There are more pages in this discussion • 256 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 98.5¢ | 95.5¢ | $193.0K | 194.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 752 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.5¢ | 365 | 2 |
View Market Depth
| Last trade - 09.44am 27/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable